Toth Financial Advisory’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18.8K | Hold |
2,001
| – | – | ﹤0.01% | 435 |
|
2025
Q1 | $10.8K | Buy |
2,001
+1,000
| +100% | +$5.42K | ﹤0.01% | 448 |
|
2024
Q4 | $7.46K | Hold |
1,001
| – | – | ﹤0.01% | 476 |
|
2024
Q3 | $8K | Buy |
+1,001
| New | +$8K | ﹤0.01% | 468 |
|
2024
Q2 | – | Sell |
-5,000
| Closed | -$103K | – | 764 |
|
2024
Q1 | $103K | Hold |
5,000
| – | – | 0.01% | 235 |
|
2023
Q4 | $116K | Buy |
5,000
+1,500
| +43% | +$34.7K | 0.02% | 228 |
|
2023
Q3 | $28K | Buy |
3,500
+2,500
| +250% | +$20K | ﹤0.01% | 323 |
|
2023
Q2 | $8.7K | Buy |
+1,000
| New | +$8.7K | ﹤0.01% | 485 |
|